102 related articles for article (PubMed ID: 38658964)
21. Emerging diagnostics and therapeutics for Alzheimer disease.
Self WK; Holtzman DM
Nat Med; 2023 Sep; 29(9):2187-2199. PubMed ID: 37667136
[TBL] [Abstract][Full Text] [Related]
22. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
Sims JR; Zimmer JA; Evans CD; Lu M; Ardayfio P; Sparks J; Wessels AM; Shcherbinin S; Wang H; Monkul Nery ES; Collins EC; Solomon P; Salloway S; Apostolova LG; Hansson O; Ritchie C; Brooks DA; Mintun M; Skovronsky DM;
JAMA; 2023 Aug; 330(6):512-527. PubMed ID: 37459141
[TBL] [Abstract][Full Text] [Related]
23. Accumulation of cytotoxic T cells in the aged CNS leads to axon degeneration and contributes to cognitive and motor decline.
Groh J; Knöpper K; Arampatzi P; Yuan X; Lößlein L; Saliba AE; Kastenmüller W; Martini R
Nat Aging; 2021 Apr; 1(4):357-367. PubMed ID: 37117598
[TBL] [Abstract][Full Text] [Related]
24. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
Chen X; Firulyova M; Manis M; Herz J; Smirnov I; Aladyeva E; Wang C; Bao X; Finn MB; Hu H; Shchukina I; Kim MW; Yuede CM; Kipnis J; Artyomov MN; Ulrich JD; Holtzman DM
Nature; 2023 Mar; 615(7953):668-677. PubMed ID: 36890231
[TBL] [Abstract][Full Text] [Related]
25. Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease.
Yang H; Park SY; Baek H; Lee C; Chung G; Liu X; Lee JH; Kim B; Kwon M; Choi H; Kim HJ; Kim JY; Kim Y; Lee YS; Lee G; Kim SK; Kim JS; Chang YT; Jung WS; Kim KH; Bae H
Theranostics; 2022; 12(18):7668-7680. PubMed ID: 36451854
[No Abstract] [Full Text] [Related]
26. Lecanemab in Early Alzheimer's Disease.
van Dyck CH; Swanson CJ; Aisen P; Bateman RJ; Chen C; Gee M; Kanekiyo M; Li D; Reyderman L; Cohen S; Froelich L; Katayama S; Sabbagh M; Vellas B; Watson D; Dhadda S; Irizarry M; Kramer LD; Iwatsubo T
N Engl J Med; 2023 Jan; 388(1):9-21. PubMed ID: 36449413
[TBL] [Abstract][Full Text] [Related]
27. Role of Chemokines in the Development and Progression of Alzheimer's Disease.
Wojcieszak J; Kuczyńska K; Zawilska JB
J Mol Neurosci; 2022 Sep; 72(9):1929-1951. PubMed ID: 35821178
[TBL] [Abstract][Full Text] [Related]
28. Crossing borders in Alzheimer's disease: A T cell's perspective.
van Olst L; Coenen L; Nieuwland JM; Rodriguez-Mogeda C; de Wit NM; Kamermans A; Middeldorp J; de Vries HE
Adv Drug Deliv Rev; 2022 Sep; 188():114398. PubMed ID: 35780907
[TBL] [Abstract][Full Text] [Related]
29.
Montagne A; Nikolakopoulou AM; Huuskonen MT; Sagare AP; Lawson EJ; Lazic D; Rege SV; Grond A; Zuniga E; Barnes SR; Prince J; Sagare M; Hsu CJ; LaDu MJ; Jacobs RE; Zlokovic BV
Nat Aging; 2021 Jun; 1(6):506-520. PubMed ID: 35291561
[TBL] [Abstract][Full Text] [Related]
30. Peripheral immunity is associated with the risk of incident dementia.
Zhang YR; Wang JJ; Chen SF; Wang HF; Li YZ; Ou YN; Huang SY; Chen SD; Cheng W; Feng JF; Dong Q; Yu JT
Mol Psychiatry; 2022 Apr; 27(4):1956-1962. PubMed ID: 35079124
[TBL] [Abstract][Full Text] [Related]
31. Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease.
Fagan SG; Bechet S; Dev KK
Mol Neurobiol; 2022 Mar; 59(3):1882-1895. PubMed ID: 35031916
[TBL] [Abstract][Full Text] [Related]
32. Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer's disease pathology.
Kummer MP; Ising C; Kummer C; Sarlus H; Griep A; Vieira-Saecker A; Schwartz S; Halle A; Brückner M; Händler K; Schultze JL; Beyer M; Latz E; Heneka MT
EMBO J; 2021 Dec; 40(24):e108662. PubMed ID: 34825707
[TBL] [Abstract][Full Text] [Related]
33. Single-Cell RNA Sequencing of Peripheral Blood Reveals Immune Cell Signatures in Alzheimer's Disease.
Xu H; Jia J
Front Immunol; 2021; 12():645666. PubMed ID: 34447367
[TBL] [Abstract][Full Text] [Related]
34. Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer's disease.
Zalocusky KA; Najm R; Taubes AL; Hao Y; Yoon SY; Koutsodendris N; Nelson MR; Rao A; Bennett DA; Bant J; Amornkul DJ; Xu Q; An A; Cisne-Thomson O; Huang Y
Nat Neurosci; 2021 Jun; 24(6):786-798. PubMed ID: 33958804
[TBL] [Abstract][Full Text] [Related]
35. Emerging Role of PD-1 in the Central Nervous System and Brain Diseases.
Zhao J; Roberts A; Wang Z; Savage J; Ji RR
Neurosci Bull; 2021 Aug; 37(8):1188-1202. PubMed ID: 33877518
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease.
Scheltens P; De Strooper B; Kivipelto M; Holstege H; Chételat G; Teunissen CE; Cummings J; van der Flier WM
Lancet; 2021 Apr; 397(10284):1577-1590. PubMed ID: 33667416
[TBL] [Abstract][Full Text] [Related]
37. CD8
Konduri V; Oyewole-Said D; Vazquez-Perez J; Weldon SA; Halpert MM; Levitt JM; Decker WK
Front Immunol; 2020; 11():613204. PubMed ID: 33597948
[TBL] [Abstract][Full Text] [Related]
38. CD8
Unger MS; Li E; Scharnagl L; Poupardin R; Altendorfer B; Mrowetz H; Hutter-Paier B; Weiger TM; Heneka MT; Attems J; Aigner L
Brain Behav Immun; 2020 Oct; 89():67-86. PubMed ID: 32479993
[TBL] [Abstract][Full Text] [Related]
39. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV
Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
[TBL] [Abstract][Full Text] [Related]
40. Dissection of the Human T-Cell Receptor γ Gene Repertoire in the Brain and Peripheral Blood Identifies Age- and Alzheimer's Disease-Associated Clonotype Profiles.
Aliseychik M; Patrikeev A; Gusev F; Grigorenko A; Andreeva T; Biragyn A; Rogaev E
Front Immunol; 2020; 11():12. PubMed ID: 32117220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
